Advanced Oncotherapy plc (LON:AVO – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 4.03 ($0.05) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares.
Advanced Oncotherapy Stock Down 9.1 %
The business’s 50 day moving average is GBX 1.93 and its 200 day moving average is GBX 4.03. The company has a debt-to-equity ratio of 98.71, a quick ratio of 0.13 and a current ratio of 1.26. The stock has a market cap of £9.46 million, a price-to-earnings ratio of -21.88 and a beta of 0.05.
Advanced Oncotherapy Company Profile
Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
See Also
- Five stocks we like better than Advanced Oncotherapy
- Investing in Travel Stocks Benefits
- These 3 Wood Stocks are about to go on Discount
- How Investors Can Identify and Successfully Trade Gap-Up Stocks
- Same Coin, Different Sides: 2 Observability Stocks Reverse Ways
- Insider Buying Explained: What Investors Need to Know
- 3 Stocks Awaiting Winter Winds of Opportunity
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
